Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引：0
|
作者：
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 697
页数：10
相关论文
共 50 条
  • [31] Optimal Treatment Duration of Neoadjuvant Endocrine Therapy for Women Aged 60 Years or Older with Estrogen Receptor-Positive, HER2-Negative Invasive Breast Cancer
    Hayashi, Yuji
    Takei, Hiroyuki
    Saito, Tsuyoshi
    Kai, Toshihiro
    Inoue, Kenichi
    Kurosumi, Masafumi
    Ninomiya, Jun
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2021, 88 (04) : 354 - 360
  • [32] Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
    Zhao, Shen
    Liu, Xi-Yu
    Jin, Xi
    Ma, Ding
    Xiao, Yi
    Shao, Zhi-Ming
    Jiang, Yi-Zhou
    THERANOSTICS, 2019, 9 (17): : 4935 - 4945
  • [33] HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
    Batra, Atul
    Kumar, Akash
    BREAST, 2021, 55 : 136 - 136
  • [34] Protein-protein interaction of HER2 predicts the prognosis of hormone receptor-positive HER2-negative breast cancer
    Choi, Hee Jun
    Lee, Hong Won
    Kim, Sangmin
    Yoon, Tae-Young
    Kim, Hyunwoo
    Lee, Seul
    Nam, Seok Jin
    Kim, Seok Won
    Cho, Sooyoun
    Park, Yeon Hee
    Lee, Jeong Eon
    CANCER RESEARCH, 2020, 80 (04)
  • [35] Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
    Funda Meric-Bernstam
    Huiqin Chen
    Argun Akcakanat
    Kim-Anh Do
    Ana Lluch
    Bryan T Hennessy
    Gabriel N Hortobagyi
    Gordon B Mills
    Ana Maria Gonzalez-Angulo
    Breast Cancer Research, 14
  • [36] Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
    Meric-Bernstam, Funda
    Chen, Huiqin
    Akcakanat, Argun
    Do, Kim-Anh
    Lluch, Ana
    Hennessy, Bryan T.
    Hortobagyi, Gabriel N.
    Mills, Gordon B.
    Gonzalez-Angulo, Ana Maria
    BREAST CANCER RESEARCH, 2012, 14 (05)
  • [37] Endocrine therapy alone in older adults with good prognosis estrogen receptor-positive breast cancer
    Israel, Irene
    Aft, Rebecca
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 75 - 76
  • [38] Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
    Meric-Bernstam, Funda
    Chen, Huiqin
    Akcakanat, Argun
    Kim-Anh Do
    Lluch, Ana
    Hennessy, Bryan
    Hortobagyi, Gabriel
    Mills, Gordon
    Gonzalez-Angulo, Ana
    CANCER RESEARCH, 2012, 72
  • [39] Co-expression of GR with PR isoforms is associated with differential prognosis in estrogen receptor-positive breast cancer
    Nimbalkar, V. P.
    Snijesh, V. P.
    Rajarajan, S.
    Patil, S.
    Anupama, C. E.
    Ramesh, R.
    Srinath, B. S.
    Prabhu, J. S.
    ANNALS OF ONCOLOGY, 2022, 33 : S142 - S142
  • [40] HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
    Hosonaga, Mari
    Arima, Yoshimi
    Sampetrean, Oltea
    Komura, Daisuke
    Koya, Ikuko
    Sasaki, Takashi
    Sato, Eiichi
    Okano, Hideyuki
    Kudoh, Jun
    Ishikawa, Shumpei
    Saya, Hideyuki
    Ishikawa, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
12345